CADILA PRODUCTS LIST

Product
Sr. No. Product Name Label Claim STD B.SIZE SFG STD B.SIZE SFG FG Shelf LIfe
Code Lead Time API -I Source Price API -II Source Price API -III

Each film coated tablet contains :

Piracetam I.P. 800mg
Citicoline Sodium I.P.
1 T044 CHOLINECAD PLUS 800 Tablets
Eq. to citicoline 500mg
145.700kg 1.0Lac 24 Months
Excipients q.s.
Colour : Titanium Dioxide I.P.
AS Per BMR Piracetam I.P. Citicoline Sodium I.P. NA
Each film coated tablet contains :
Ciprofloxacin HCL I.P.
2 T038 CADIWIN 250 Eq. to Ciprofloxacin 250mg 222.068KG 5.50LAC 24 Months
Excipients q.s.
Colour : Titanium Dioxide I.P. AS Per BMR Ciprofloxacin HCL I.P. NA NA NA NA
Each film coated tablet contains :
Ciprofloxacin HCL I.P.
3 T041 CADIWIN 500 Tablets Eq. to Ciprofloxacin 500mg 383.500KG 5.0LAC 24 Months
Excipients q.s.
Colour : Titanium Dioxide I.P. AS Per BMR Ciprofloxacin HCL I.P. NA NA NA NA
Each film coated tablet contains :
Rosuvastatin Calcium I.P.
Eq. to Rosuvastatin 10mg
4 T394 ROSUBEST-F Tablet
Fenofibrate I.P. 160mg
168.0kg 6.0Lac 24 Months
Excipients q.s.
Colour : Titanium Dioxide I.P. AS Per BMR Rosuvastatin Calcium I.P. NA NA NA NA
Each uncoated tablet contains:
Mefenamic Acid IP 250mg
5 T114 PARASPAS Tablets Dicyclomine HCL IP 10mg 490.0KG 10.0LAC 24 Months
Excipients q.s.
Colour : Tartrazine AS Per BMR Mefenamic Acid IP Dicyclomine HCL IP NA
Each 5ml contains:
Cyproheptadine HCL (Anhydrous) I.P. 2mg
Tricholine Citrate Solution (65%) 275mg
6 L158 CADEPTIN PLUS Syrup
Sorbitol Solution (70%) I.P. q.s.
5000LTR 25000BTL 24 Months
Sorbitol Solution
(Non-Crystallizing) Cyproheptadine HCL Tricholine Citrate (70%) I.P.
In a flavoured base q.s. AS Per BMR (Anhydrous) I.P. Solution (65%) Preservative
Each 5ml contains:
Cyproheptadine HCL (Anhydrous) I.P. 2mg
Tricholine Citrate Solution (65%) 275mg
7 L159 ADD APP PLUS Syrup
Sorbitol Solution (70%) I.P. q.s.
5000LTR 25000BTL 24 Months
Sorbitol Solution
(Non-Crystallizing) Cyproheptadine HCL Tricholine Citrate (70%) I.P.
In a flavoured base q.s. AS Per BMR (Anhydrous) I.P. Solution (65%) Preservative
Each hard gelatin capsule contains:
Esomeprazole Magnesium Trihydrate I.P.
Eq. to Esomeprazole 40mg
8 C047 Esotrax-RD Capsule (as enteric coated pellets) 143.0KG 5.0LAC 24 Months
Domperidone I.P. 30mg
(as sustained release pellets) Esomeprazole Magnesium
Excipients q.s. AS Per BMR Trihydrate I.P Domperidone I.P.
Each uncoated tablet contains:
Glimepiride IP 1mg.
Pioglitazone hydrochloride IP
Eq. to Pioglitazone 15mg.
9 T346 GLISTA PM-1 435.0KG 5.0LAC 24 Months
Metformin Hydrochloride IP 500mg.
(As sustained release form)
Excipients q.s.
Colour: Erythrosine Lake AS Per BMR Glimepride I.P. Pioglitazone metformin HCl
Each uncoated tablet contains:
Glimepiride IP 2mg.
Pioglitazone hydrochloride IP
Eq. to Pioglitazone 15mg.
10 T353 GLISTA PM-2 517.806KG 6.0Lac 24 Months
Metformin Hydrochloride IP 500mg.
(As sustained release form)
Excipients q.s.
Colour: Brilliant Blue FCF. AS Per BMR Glimepride I.P. Pioglitazone metformin HCl
Source Price

NA NA

NA NA

NA NA

NA NA

NA NA
 Used Content Name
S. No. Product Name Batch No. Mfg Date Exp Date
Glycerin / Propylene
Glycol / Sorbitol
Glycerin / Propylene
1 CYHEP PLUS L30754A Dec/23 Nov/25
Glycol / Sorbitol
2 MUCOCIL LS 100 ML L30726A Dec/23 Nov/25 Propylene Glycol
 Excipients Batch No. Excipients Ar. No.

Propylene
Glycerin Propylene Glycol Sorbitol Glycerin
Glycol
10-23P092 PG-IP/2023-24/2321 871 RM/1781/2023 RM/1584/2023
PG-IP/2023-24/2321 RM/1584/2023
ents Ar. No.

Sorbitol

RM/1615/2023
 HOLD TIME STUDY DATE PLANNER PREGABLIN 300 CAPS
Test
Frequency
Stage Water
(Day) Description Assay Bulk Density
Content
initial 27/01/2024 27/01/2024 27/01/2024 27/01/2024
7 03/02/2024 03/02/2024 03/02/2024 x
Bulk

15 12/02/2024 12/02/2024 12/02/2024 x

30 27/02/2024 27/02/2024 27/02/2024 27/02/2024

Test
Frequency
Stage Dissolution Relative
(Day) Description Assay
Test substances
initial 27/01/2024 27/01/2024 27/01/2024 27/01/2024
Filled capsules

15 12/02/2024 x x x
30 27/02/2024 27/02/2024 27/02/2024 27/02/2024
45 13/03/2024 x x x
60 27/03/2024 27/03/2024 27/03/2024 27/03/2024
90 26/04/2024 26/04/2024 26/04/2024 26/04/2024

PREDNISOLONE 5MG TABLETS BP

Test
Frequency
Stage Water
(Day) Description Assay Bulk Density
Content
initial 27/01/2024 27/01/2024 27/01/2024 27/01/2024
7 03/02/2024 03/02/2024 03/02/2024 x
Bulk

15 12/02/2024 12/02/2024 12/02/2024 x

30 27/02/2024 27/02/2024 27/02/2024 27/02/2024

Test
Frequency
Stage Dissolution Relative
(Day) Description Assay
Test substances
initial 27/01/2024 27/01/2024 27/01/2024 27/01/2024
15 12/02/2024 x x x
Tablet

30 27/02/2024 27/02/2024 27/02/2024 27/02/2024

45 13/03/2024 x x x
60 27/03/2024 27/03/2024 27/03/2024 27/03/2024
90 26/04/2024 26/04/2024 26/04/2024 26/04/2024
LIN 300 CAPS

Microbial
Cont.

27/01/2024
03/02/2024
12/02/2024
27/02/2024

Microbial
Cont.

27/01/2024
12/02/2024
27/02/2024
13/03/2024
27/03/2024
26/04/2024

Microbial
Cont.

27/01/2024
03/02/2024
12/02/2024
27/02/2024

Microbial
Cont.

27/01/2024
12/02/2024
27/02/2024
13/03/2024
27/03/2024
26/04/2024